This multicenter Cardiovascular Research Network (CVRN) collaborative project will examine the risks and benefits of targeted medical therapies used for heart failure across the spectrum of multimorbidity burden and level of left ventricular systolic function, as well as several targeted comorbidity dyads including heart failure plus diabetes and heart failure plus anemia.